Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia

Cancer Genetics and Cytogenetics

Volumn 126, Issue 1, 2001, Pages 8-12

  Nishii, Kazuhiro ^a   Usui, Eiji ^a   Sakakura, Miho ^a   Miyata, Eri ^a   Ridge, Susan A ^b   Ford, Anthony M ^b   Masuya, Masahiro ^a   Chen, Fawen ^a   Mitani, Hidetugu ^a   Yamaguchi, Motoko ^a   Katayama, Naoyuki ^a   Kita, Kenkichi ^a   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY   (Japan)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD19 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD7 ANTIGEN; CYTARABINE; FIBRINOGEN RECEPTOR; HYBRID PROTEIN; IDARUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; LYMPHOCYTE SURFACE MARKER; MICROSOMAL AMINOPEPTIDASE; T CELL RECEPTOR GAMMA CHAIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; BONE MARROW; CASE REPORT; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE REARRANGEMENT; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPE; METAPHASE; NEUTROPHIL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ADULT; ANTIGENS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, SOUTHERN; BONE MARROW TRANSPLANTATION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; COMBINED MODALITY THERAPY; DNA-BINDING PROTEINS; FEMALE; FUSION PROTEINS, BCR-ABL; GENOTYPE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTO-ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0035305436     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00382-4     Document Type: Article

References (23)

1. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients
2. Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL
3. The karyotype of blastic crisis
4. Chromosome 3q21 abnormalities associated with hyperactive thrombopoiesis in acute blastic transformation of chronic myeloid leukemia
5. t(14;14)(q11;q32) in biphenotypic blastic phase of chronic myeloid leukemia
6. c-kit gene expression in CD7-positive acute lymphoblastic leukemia; close correlation with expression of myeloid-associated antigen CD13
7. Expression of B-cell associated transcription factors in precursor B-cell acute lymphoblastic leukemia cells; association with PU.1 expression, phenotype, and immunogenotype
8. Consistent amounts of acute leukemia-associated p190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis
9. The role of alternative splicing patterns of BCR/ABL transcripts in the generation of the blast crisis of chronic myeloid leukemia
10. Childhood acute lymphoblastic leukemia with chromosomal breakpoints at 11q23
11. 11q23 rearrangements in acute leukemia
12. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia
13. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias
14. MLL rearrangements in haematological malignancies; lessons from clinical and biological studies
15. ALL-1 gene rearrangements in acute myeloid leukemia; Association with M4-M5 French-American-British classification subtypes and young age
16. General report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997
17. Ten novel 11q23 chromosomal partner sites. European 11q23 workshop participants
18. A case of chronic myelogenous leukemia with 11q- in blast crisis with monoblastic differentiation
19. Significance of secondary cytogenetic changes in patients with Ph-positive chronic granulocytic leukemia in the acute phase
20. Karyotype evolution of Ph positive chronic myelogenous leukemia patients relapsed in advanced phases of the disease after allogeneic bone marrow transplantation
21. t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemia
22. Blastic phase chronic myeloid leukemia with a four-break rearrangement; t(11;9)(9;22)(q23;p22q34;q11)
23. Unusual clinical course and acquisition of del(11)(q23) in second lymphatic blastic phase of a Ph-positive chronic myeloid leukemia